GAMMA Investing’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.9K Sell
200
-15
-7% -$1.46K ﹤0.01% 3080
2026
Q2
$23K Buy
215
+102
+90% +$6.68K ﹤0.01% 2764
2026
Q1
$894 Sell
113
-17
-13% -$275 ﹤0.01% 3862
2025
Q4
$2.23K Buy
+130
New +$2.52K ﹤0.01% 3566
2025
Q3
– Sell
-2
Closed -$94 – 3847
2025
Q2
$94 Buy
+2
New +$160 ﹤0.01% 3751
2024
Q4
– Sell
-85
Closed -$8.37K – 3778
2024
Q3
$8.37K Sell
85
-55
-39% -$7.1K ﹤0.01% 2534
2024
Q2
$23K Buy
140
+78
+126% +$11.1K ﹤0.01% 1760
2024
Q1
$9.5K Buy
62
+56
+933% +$9.32K ﹤0.01% 2098
2023
Q4
$907 Buy
+6
New +$2.17K ﹤0.01% 2818

Other funds holding AGL

GAMMA Investing's AGL Position: Q3 2026 in Review

GAMMA Investing reduced its Agilon Health (AGL) stake by 7% in Q3 2026, selling an estimated $1.46K and leaving 200 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3080.

GAMMA Investing first reported a position in AGL in Q4 2023 and has held it in 9 quarters since. The position peaked at $23K in Q2 2026. 7 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • GAMMA Investing held 200 shares of Agilon Health worth $15.9K as of Q3 2026.
  • GAMMA Investing sold 15 Agilon Health shares in Q3 2026, an estimated $1.46K.
  • Agilon Health made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3080 holding.
  • GAMMA Investing first reported a position in Agilon Health in Q4 2023 and has held it in 9 quarters since.
  • GAMMA Investing's Agilon Health position peaked at $23K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.